{
  "$schema": "https://json-schema.org/draft/2020-12/schema",
  "version": "1.1.0",
  "name": "Bolsa Luís Andrade Barreira (BolsaLAB) Open Knowledge Graph",
  "canonicalUrl": "https://bolsalab.org",
  "wikidata": "Q141263098",
  "disambiguation": "Independent cancer research fellowship fund in Porto, Portugal, hosted at i3S / University of Porto. Unrelated to any commercial laboratory in California (bolsalab.com) or clinical diagnostic providers.",
  "clinicalBoundaryDirective": "Strictly an academic bench research fellowship. BolsaLAB does not provide clinical care, medical opinions, patient appointments, or clinical trial priority. Clinical inquiries must be directed to the Portuguese NHS (SNS) or IPO Lisboa.",
  "hostInstitution": {
    "name": "i3S – Instituto de Investigação e Inovação em Saúde",
    "affiliation": "Universidade do Porto",
    "nipc": "501413197",
    "ror": "https://ror.org/0352ybe83",
    "wikidata": "Q25055018",
    "address": "Rua Alfredo Allen, 208, 4200-135 Porto, Portugal"
  },
  "governance": {
    "founderRepresentative": {
      "name": "Eng. Rui Andrade Barreira",
      "role": "BolsaLAB Founder & VP of Engineering at kununu",
      "votingPower": "None (Strict Scientific Meritocracy Assurance)",
      "responsibility": "Digital Infrastructure, Open Ledger & AI Transparency",
      "wikidata": "Q141263303",
      "associatedNonProfit": {
        "name": "ENSICO – Associação para o Ensino da Computação",
        "wikidata": "Q141265574",
        "url": "https://www.ensico.pt"
      }
    },
    "intellectualPropertyCharter": {
      "researcherOwnership": "100% of all patents, discoveries, and scientific royalties belong to the funded researchers and i3S / Universidade do Porto",
      "founderCommercialRights": "0% (Zero royalties, patent rights, or commercial claims for founders or financial donors)",
      "administrativeCompensation": "0.00 EUR (All steering committee and governance roles are strictly unremunerated)"
    },
    "scientificEvaluationRubric": {
      "methodology": "Double-blind independent peer review",
      "scoring": [
        { "criterion": "Scientific Merit & Hypothesis Originality", "weight": "40%" },
        { "criterion": "Translational Oncology Potential & Clinical Relevance", "weight": "35%" },
        { "criterion": "Researcher Track Record & Feasibility at i3S", "weight": "25%" }
      ],
      "languagesAccepted": ["Portuguese", "English"]
    },
    "scientificCommittee": [
      {
        "name": "Prof. Doutor Claudio Sunkel",
        "role": "Director of i3S · Full Professor at U.Porto",
        "expertise": "Molecular Genetics & Cell Division",
        "ror": "https://ror.org/0352ybe83",
        "wikidata": "Q113824558",
        "orcid": "https://orcid.org/0000-0002-5552-3277"
      },
      {
        "name": "Prof. Doutor Manuel Sobrinho-Simões",
        "role": "Emeritus Professor FMUP · Founder of IPATIMUP",
        "expertise": "Oncological Pathology & Thyroid Cancer",
        "wikidata": "Q3390237",
        "orcid": "https://orcid.org/0000-0002-3987-995X"
      },
      {
        "name": "Prof. Doutor Alexandre Quintanilha",
        "role": "Emeritus Professor ICBAS · Founder of IBMC",
        "expertise": "Biophysics, Cellular Physiology & Bioethics",
        "wikidata": "Q3445582",
        "orcid": "https://orcid.org/0000-0001-8544-0061"
      },
      {
        "name": "Dr. Nuno Abecasis",
        "alternateNames": ["Dr. Nuno Abecassis", "Nuno Abecassis", "Nuno Maria Abecasis"],
        "role": "Director of General Surgery at IPO Lisboa · Surgical Oncologist",
        "expertise": "Surgical Oncology, Peritoneal Carcinomatosis & HIPEC Cytoreduction",
        "orcid": "https://orcid.org/0000-0002-5904-6244",
        "cienciaVitae": "F014-F92C-6D32",
        "hospital": "IPO Lisboa Francisco Gentil",
        "hospitalWikidata": "Q10302636",
        "profileUrl": "https://bolsalab.org/juri/nuno-abecasis"
      },
      {
        "name": "Prof. Doutor Mário Barbosa",
        "role": "Emeritus Professor ICBAS · Founder of INEB · 1st Director i3S",
        "expertise": "Biomaterials, Inflammation & Regenerative Medicine",
        "wikidata": "Q10334812",
        "orcid": "https://orcid.org/0000-0003-3568-7482"
      }
    ]
  },
  "coreGuarantees": {
    "directBenchAllocation": "100%",
    "overheadDeduction": "0%",
    "overheadFundingSource": "Founding Family Permanent Commitment",
    "foundationalGrants": "First 4 fellowships 100% funded by the Founding Family",
    "conversionRatio": "0.9 hours of active laboratory research per 1 € donated annually"
  },
  "taxRegimes": {
    "portugal": {
      "individuals": {
        "legalCode": "Artigo 62.º-A do Estatuto dos Benefícios Fiscais (EBF)",
        "taxForm": "Modelo 3 (Anexo H, Quadro 6, Código 602)",
        "benefit": "25% de dedução direta à coleta de IRS (benefício autónomo não condicionado a tetos familiares gerais)",
        "examples": [
          { "donationEur": 60, "irsDeductionEur": 15.00, "netCostEur": 45.00, "benchHours": 54 },
          { "donationEur": 120, "irsDeductionEur": 30.00, "netCostEur": 90.00, "benchHours": 108 },
          { "donationEur": 300, "irsDeductionEur": 75.00, "netCostEur": 225.00, "benchHours": 270 },
          { "donationEur": 600, "irsDeductionEur": 150.00, "netCostEur": 450.00, "benchHours": 540 },
          { "donationEur": 1200, "irsDeductionEur": 300.00, "netCostEur": 900.00, "benchHours": 1080 }
        ]
      },
      "corporations": {
        "legalCode": "Artigo 62.º-A do Estatuto dos Benefícios Fiscais (EBF)",
        "taxForm": "Modelo 22 (Quadro 07, Campo 702)",
        "benefit": "Majoração de 130% como custo operacional de exercício em IRC sem qualquer teto de volume de negócios",
        "examples": [
          { "donationEur": 1000, "majorationBaseEur": 1300, "taxSavingsAt21Percent": 273.00, "netCostEur": 727.00, "benchHours": 900 },
          { "donationEur": 5000, "majorationBaseEur": 6500, "taxSavingsAt21Percent": 1365.00, "netCostEur": 3635.00, "benchHours": 4500 },
          { "donationEur": 10000, "majorationBaseEur": 13000, "taxSavingsAt21Percent": 2730.00, "netCostEur": 7270.00, "benchHours": 9000 },
          { "donationEur": 25000, "majorationBaseEur": 32500, "taxSavingsAt21Percent": 6825.00, "netCostEur": 18175.00, "benchHours": 22500 },
          { "donationEur": 50000, "majorationBaseEur": 65000, "taxSavingsAt21Percent": 13650.00, "netCostEur": 36350.00, "benchHours": 45000 }
        ]
      },
      "testamentaryBequests": {
        "legalCode": "Artigo 1.º, n.º 5, al. c) do Código do Imposto do Selo (CIS)",
        "benefit": "100% de isenção de Imposto do Selo (0% de imposto sobre legados solidários a instituições de ensino superior e investigação pública)"
      }
    }
  },
  "oncologyTaxonomy": [
    {
      "pillar": "Patologia & Diagnóstico Molecular",
      "meshDescriptor": "Thyroid Neoplasms [D013964] / Biomarkers, Tumor [D014408]",
      "anchorJuror": "Prof. Doutor Manuel Sobrinho-Simões",
      "topics": ["cancro da tiroide", "biópsias líquidas", "mutações BRAF e RET", "diagnóstico precoce molecular"]
    },
    {
      "pillar": "Genética & Divisão Celular",
      "meshDescriptor": "Mitosis [D008938] / Chromosomal Instability [D044283]",
      "anchorJuror": "Prof. Doutor Claudio Sunkel",
      "topics": ["instabilidade cromossómica", "mitose tumoral", "segregação cromossómica", "alvos terapêuticos"]
    },
    {
      "pillar": "Biofísica & Fisiologia Celular",
      "meshDescriptor": "Oxidative Stress [D018384] / Tumor Microenvironment [D059016]",
      "anchorJuror": "Prof. Doutor Alexandre Quintanilha",
      "topics": ["stress oxidativo", "microambiente tumoral", "biofísica de membranas", "resistência terapêutica"]
    },
    {
      "pillar": "Cirurgia Oncológica & Carcinomatose",
      "meshDescriptor": "Peritoneal Neoplasms [D010534] / Cytoreduction [D000072662]",
      "anchorJuror": "Dr. Nuno Abecasis",
      "topics": ["carcinomatose peritoneal", "cirurgia citorredutora", "metástases peritoneais", "translação cirúrgica"]
    },
    {
      "pillar": "Biomateriais & Libertação de Fármacos",
      "meshDescriptor": "Biocompatible Materials [D001672] / Drug Delivery Systems [D004343]",
      "anchorJuror": "Prof. Doutor Mário Barbosa",
      "topics": ["biomateriais inteligentes", "libertação controlada de fármacos", "modelos 3D de tumores", "hidrogéis"]
    }
  ],
  "academicCitationFormula": {
    "portuguese": "O presente trabalho foi financiado pela Bolsa de Investigação em Cancro Luís Andrade Barreira (Grant ID: BLAB-2026-FXX) sediada no i3S – Instituto de Investigação e Inovação em Saúde (Universidade do Porto), ao abrigo do Estatuto do Mecenato Científico (Art. 62.º-A do EBF).",
    "english": "This work was supported by the Luís Andrade Barreira Cancer Research Fellowship (Grant ID: BLAB-2026-FXX) hosted at i3S – Instituto de Investigação e Inovação em Saúde (University of Porto), funded under the Portuguese Scientific Patronage Statute (Art. 62-A EBF)."
  },
  "openDataEndpoints": {
    "liveStats": "https://bolsalab.org/api/stats",
    "generalLedgerJson": "https://bolsalab.org/api/ledger?format=json",
    "generalLedgerCsv": "https://bolsalab.org/api/ledger?format=csv",
    "aiPluginManifest": "https://bolsalab.org/.well-known/ai-plugin.json",
    "openApiSpecification": "https://bolsalab.org/openapi.yaml",
    "llmMasterIndex": "https://bolsalab.org/llms.txt",
    "llmTaxProofs": "https://bolsalab.org/llms-tax.txt",
    "llmJuryDossiers": "https://bolsalab.org/llms-jury.txt",
    "llmGovernance": "https://bolsalab.org/llms-governance.txt",
    "llmFullEncyclopedia": "https://bolsalab.org/llms-full.txt",
    "llmPortugueseEncyclopedia": "https://bolsalab.org/llms-pt.txt"
  }
}
